Professor, Internal Medicine, University of Virginia School of Medicine
Endocrinology
Dr. Anthony L. McCall, MD
|
|
Give Review
Dr. Anthony L. McCall works in the field of Endocrinology. He attended Medical College of Wisconsin. Medical College of Wisconsin has a rank of 54 in research and a 62 in primary care He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Anthony McCall is a published doctor. He has 62 papers published. The most current publication "Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand: increased protein half-life." Anthony McCall is registered with Medicare and accepts Medicare payments.
Publications
- Impact of Behavioral Interventions in the Management of Adults with Type 2 Diabetes Mellitus.
- Association of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetes.
- Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
- What''s wrong with too low? Is hypoglycemia a marker or a cause of CVD and mortality risk?
- Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.
- Is there a magic diet? Studying the balance of macronutrients needed for best weight loss.
- Update on the safety of thiazolidinediones.
- Pancreatic network control of glucagon secretion and counterregulation.
- When is evidence of lack of harm enough? Has the rosiglitazone controversy ended?
- Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine.
- The median is not the only message: a clinician''s perspective on mathematical analysis of glycemic variability and modeling in diabetes mellitus.
- System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency.
- Does the method of obtaining glycemic control influence cardiovascular outcomes?
- Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.
- Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.
- Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.
- Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers.
- Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes.
- A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus.
- What to inject when oral agents fail?
- Altered glycemia and brain-update and potential relevance to the aging brain.
- Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.
- Starting insulin therapy in type 2 diabetes: lesson 1.
- Starting insulin therapy in type 2 diabetes: lesson 2.
- Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.
- Hypertension management in patients with diabetic nephropathy.
- Cerebral glucose metabolism in diabetes mellitus.
- Reducing CVD risk in type 2 DM.
- Diabetes mellitus and the central nervous system.
- The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes.
- GLUT8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus.
- Factor(s) released by glucose-deprived astrocytes enhance glucose transporter expression and activity in rat brain endothelial cells.
- Clinical review of glimepiride.
- Parental medical neglect in the treatment of adolescents with anorexia nervosa.
- Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress.
- Regulation of GLUT-3 glucose transporter in the hippocampus of diabetic rats subjected to stress.
- Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand: increased protein half-life.
- Effects of dexamethasone in vivo and in vitro on hexose transport in brain microvasculature.
- Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain.
- IDDM, counterregulation, and the brain.
- Glucose transporter expression in L6 muscle cells: regulation through insulin- and stress-activated pathways.
- Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons.
- Forebrain endothelium expresses GLUT4, the insulin-responsive glucose transporter.
- Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study.
- Chronic seizures increase glucose transporter abundance in rat brain.
- Coupled glucose transport and metabolism in cultured neuronal cells: determination of the rate-limiting step.
- Localization of glucose transporter GLUT 3 in brain: comparison of rodent and dog using species-specific carboxyl-terminal antisera.
- Progressive hippocampal loss of immunoreactive GLUT3, the neuron-specific glucose transporter, after global forebrain ischemia in the rat.
- Immunohistochemical localization of the neuron-specific glucose transporter (GLUT3) to neuropil in adult rat brain.
- An immunization method for generation of high affinity antisera against glucose transporters useful in immunohistochemistry.
- The impact of diabetes on the CNS.
- Could intranasal insulin be useful in the treatment of non-insulin-dependent diabetes mellitus?
- Chronic exposure to high glucose decreases myo-inositol in cultured cerebral microvascular pericytes but not in endothelium.
- Effects of hypoglycemia and diabetes on fuel metabolism by rat brain microvessels.
- Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man.
- Chronic hypoglycemia increases brain glucose transport.
- Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.
- Diabetes-induced alterations of glucose metabolism in rat cerebral microvessels.
- Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus.
- Non-saturable transport of 3Hoestradiol across the blood-brain barrier in female rats is reduced by neonatal serum.
- Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift.
Schools
Medical College of Wisconsin
University Hospital
Boston City Hospital
Procedures Preformed
- Continuous Glucose Monitoring
Doctors Specialties
- Internal Medicine
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Boston University Medical Center -
Medical College of Wisconsin
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1023187655 | |
| NPPES Provider LastName | MCCALL | |
| NPPES Provider FirstName | ANTHONY | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 936.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 1.18 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023187655 |
| Last Name Of The Provider | MCCALL |
| First Name Of The Provider | ANTHONY |
| View All |
Similar Doctors
|
Dr. Alan C. Dalkin, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Mary Lee VanCe, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura A. Ricciardi, MD |
|
|
Dr. Helmy M. Siragy, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Zhenqi Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kara B. Hawkins, MD
This Doctor is OpenDoctor Recommended.
|